AIDS Unrelenting

Figure 1Figure 2An estimated 5 million people became infected with HIV worldwide in 2003, and as many as 3 million died from AIDS, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The total number of infected people worldwide is estimated at 40 million. Nowhere has been hit as devastatingly as Sub-Saharan Africa, which bears as much as 67% of the world's infected and roughly 3/4 of the deaths for 2003. In this area, prevalence among adults ranges from less than 1-in-100 in M


Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

An estimated 5 million people became infected with HIV worldwide in 2003, and as many as 3 million died from AIDS, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The total number of infected people worldwide is estimated at 40 million. Nowhere has been hit as devastatingly as Sub-Saharan Africa, which bears as much as 67% of the world's infected and roughly 3/4 of the deaths for 2003. In this area, prevalence among adults ranges from less than 1-in-100 in Mauritania to nearly 2-in-5 in Botswana. Predictions in Africa are made largely on data collected from antenatal clinics. The UNAIDS report attributes seeming declines over its own past estimates to better monitoring and statistical correction of data. The pandemic in Africa continues to grow, as do more recent epidemics in Asia, Southeast Asia, the Baltic States, and elsewhere.

Here, regional numbers indicate deaths in adults and children due ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio
Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio